Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarin-treated patients from control subjects

Obrant, Karl LU ; Kakonen, S M ; Astermark, Jan LU ; Lilja, Hans LU orcid ; Lovgren, T ; Åkesson, Kristina LU and Pettersson, K (1999) In Journal of Bone and Mineral Research 14(4). p.555-560
Abstract
We assessed the serum concentration of gamma-carboxylated osteocalcin (OC), total OC, and full-length OC in a clinical setting of 37 patients on continuous warfarin treatment (international normalized ratio 2.0-3.8). A comparison was done with the results from 30 untreated age-matched controls. Four monoclonal antibodies, previously generated and characterized as to their ability to recognize different human OC forms and fragments, were used in three two-site immunofluorometric assays. The warfarin-treated patients had significantly lower levels of carboxylated OC 4.9 +/- 3.8 (+/- 1 SD) ng/ml compared with the controls 13.1 +/- 9.7 (p < 0.0001). There was no difference in the levels of total OC or full-length OC between the two groups... (More)
We assessed the serum concentration of gamma-carboxylated osteocalcin (OC), total OC, and full-length OC in a clinical setting of 37 patients on continuous warfarin treatment (international normalized ratio 2.0-3.8). A comparison was done with the results from 30 untreated age-matched controls. Four monoclonal antibodies, previously generated and characterized as to their ability to recognize different human OC forms and fragments, were used in three two-site immunofluorometric assays. The warfarin-treated patients had significantly lower levels of carboxylated OC 4.9 +/- 3.8 (+/- 1 SD) ng/ml compared with the controls 13.1 +/- 9.7 (p < 0.0001). There was no difference in the levels of total OC or full-length OC between the two groups of patients. A strong correlation was found between the serum concentration of carboxylated OC and total OC, both for the warfarin-treated patients (r = 0.98) and for the controls (r = 0.99). There was a distinct cut-off level at 0.80, in the quotient carboxylated OC/total OC, at which all warfarin-treated patients fell below and all controls above this level. Hence, the concentration or ratio of serum gamma-carboxylated OC in clinical settings such as warfarin-treated patients could be measured using two-site immunoassays. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Bone and Mineral Research
volume
14
issue
4
pages
555 - 560
publisher
Wiley-Blackwell
external identifiers
  • pmid:10234576
  • scopus:0344628892
ISSN
1523-4681
DOI
10.1359/jbmr.1999.14.4.555
language
English
LU publication?
yes
additional info
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Clinical and Molecular Osteoporosis Research Unit (013242930), Emergency medicine/Medicine/Surgery (013240200), Clinical Chemistry, Malmö (013016000)
id
140625d3-f0be-4f00-9533-792f7807d55a (old id 1114957)
date added to LUP
2016-04-01 12:00:49
date last changed
2022-04-05 08:17:50
@article{140625d3-f0be-4f00-9533-792f7807d55a,
  abstract     = {{We assessed the serum concentration of gamma-carboxylated osteocalcin (OC), total OC, and full-length OC in a clinical setting of 37 patients on continuous warfarin treatment (international normalized ratio 2.0-3.8). A comparison was done with the results from 30 untreated age-matched controls. Four monoclonal antibodies, previously generated and characterized as to their ability to recognize different human OC forms and fragments, were used in three two-site immunofluorometric assays. The warfarin-treated patients had significantly lower levels of carboxylated OC 4.9 +/- 3.8 (+/- 1 SD) ng/ml compared with the controls 13.1 +/- 9.7 (p &lt; 0.0001). There was no difference in the levels of total OC or full-length OC between the two groups of patients. A strong correlation was found between the serum concentration of carboxylated OC and total OC, both for the warfarin-treated patients (r = 0.98) and for the controls (r = 0.99). There was a distinct cut-off level at 0.80, in the quotient carboxylated OC/total OC, at which all warfarin-treated patients fell below and all controls above this level. Hence, the concentration or ratio of serum gamma-carboxylated OC in clinical settings such as warfarin-treated patients could be measured using two-site immunoassays.}},
  author       = {{Obrant, Karl and Kakonen, S M and Astermark, Jan and Lilja, Hans and Lovgren, T and Åkesson, Kristina and Pettersson, K}},
  issn         = {{1523-4681}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{555--560}},
  publisher    = {{Wiley-Blackwell}},
  series       = {{Journal of Bone and Mineral Research}},
  title        = {{The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarin-treated patients from control subjects}},
  url          = {{http://dx.doi.org/10.1359/jbmr.1999.14.4.555}},
  doi          = {{10.1359/jbmr.1999.14.4.555}},
  volume       = {{14}},
  year         = {{1999}},
}